论文部分内容阅读
作者对氨苯砜或氯苯吩嗪(B_(663))治疗的16名结核样型病人、22名瘤型病人以及18名健康人,进行了巨噬细胞移动抑制试验,观察在有特异性抗原——麻风菌苗(Leprolin)时麻风的淋巴细胞和巨噬细胞(麻风病人的血中单核细胞)的表现,即在麻风菌苗的刺激下,麻风病人的淋巴细胞产生巨噬细胞移动抑制因子(MIF)的能力和麻风病人的巨噬细胞对MIF反应的能力。巨噬细胞移动抑制的程度用移动指数表示。
The authors tested 16 patients with tuberculoid type, 22 patients with tuberculous type and 18 healthy people treated with dapsone or clofenzin (B_ (663)) and tested their macrophage migration inhibition. Antigen - The manifestation of leprosy of lymphocytes and macrophages (leprosy blood mononuclear cells) at the time of Leprolin, that is, leprosy lymphocytes produce macrophage migration by leprosy vaccine Inhibitory factor (MIF) and the ability of macrophages of leprosy to respond to MIF. The extent of macrophage migration inhibition is indicated by the mobility index.